Speciality: Physician (Internal Medicine)
Description:
A warm welcome to all the medical professionals in this interesting session on A Gastro-Rheum Cross talk: Connections between the gut, joint, and spine.
The connection between the gut, joints, and spine highlights the intricate relationship between the gastrointestinal and musculoskeletal systems, often referred to as the gut-joint axis. Conditions like inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, can have significant rheumatologic manifestations, such as peripheral arthritis, axial spondyloarthritis, and sacroiliitis. This overlap suggests a shared inflammatory pathway that links gut inflammation with joint and spine disorders.
Research has shown that gut microbiota plays a crucial role in this connection, influencing the immune system and potentially triggering systemic inflammation that affects joints and the spine. Dysbiosis, or imbalance in gut bacteria, has been implicated in the development and exacerbation of both IBD and spondyloarthritis. This understanding has led to a more integrated approach to treating patients with these conditions, focusing on both gastrointestinal and rheumatologic symptoms.
Therefore, get an overall knowledge of a gastro-rheum cross talk: connections between the gut, joint, and spine.
See More Webinars @ Hidoc Webinars
1.
Advances in "next generation" photoactive cancer therapy
2.
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
3.
The American College of Physicians updated its recommendations for colorectal cancer screening.
4.
Optimizing Sequencing of BCMA-Directed Therapies in Myeloma
5.
According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.
1.
Quality of Life Using Precision Functional Recovery After Organ-Preserving Interventions
2.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
3.
Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy
4.
Modern Developments in Oncology for Specialists
5.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
Navigating the Complexities of Ph Negative ALL - Part XII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation